Clinical Trial Update: Embosphere® PROstate Post Market Study

View source ↗

Summary

Post-market study update for Embosphere in benign prostatic hyperplasia and lower urinary tract symptoms; study completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Lower Urinary Tract Symptoms

Drugs mentioned

• Embosphere

Snippet

Sponsor: Merit Medical Systems, Inc. | Conditions: Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms | Status: COMPLETED | Results posted: 2023-12-18